{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:58:51Z","timestamp":1790675931968,"version":"4.1.0"},"reference-count":28,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2012,6,25]],"date-time":"2012-06-25T00:00:00Z","timestamp":1340582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Pharm &amp; Therapeutics"],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:p>Freise, K.J., Savides, M.C., Riggs, K.L., Owens, J.G., Newbound, G.C., Clark, T.P. Pharmacokinetics and dose selection of a novel, long\u2010acting transdermal fentanyl solution in healthy laboratory Beagles.<jats:italic>J. vet. Pharmacol. Therap.<\/jats:italic><jats:bold>35<\/jats:bold>(Suppl. 2), 21\u201326.<\/jats:p><jats:p>A novel, transdermal fentanyl solution (TFS) was developed that delivers sustained concentrations of fentanyl for days following a single application. The pharmacokinetics following a single topical dose was examined. Eighteen adult Beagle dogs were divided into three groups of six dogs (3M, 3F). Each group was administered a single dose of 1.3 (25), 2.6 (50), or 5.2\u2003mg\/kg (100\u2003\u03bcL\/kg) of TFS. The dose was applied to the clipped, ventral abdominal skin using a 1\u2010mL tuberculin syringe. Immediately following dosing, collars were placed on each dog through 72\u2003h to prevent direct licking of the application site. Serial jugular venous blood samples were collected at 0 (predosing), 1, 2, 4, 6, 8, 12, 24, 36, 48, 60, 72, 84, 96, 108, 120, 144, 168, 240, 336, 408, and 504\u2003h after dosing and assayed for plasma fentanyl concentration. Fentanyl was rapidly detected following application with a mean absorption lag time (<jats:italic>t<\/jats:italic><jats:sub>lag<\/jats:sub>) of 0.333\u2003h in the 1.3\u2003mg\/kg group and 0 in the other two groups. The mean C<jats:sub>max<\/jats:sub>increased with dose and were 2.28, 2.67, and 4.71\u2003ng\/mL in the 1.3, 2.6 and 5.2\u2003mg\/kg dose groups, respectively. Mean terminal half\u2010lives were 53.7, 69.6, and 103\u2003h in the 1.3, 2.6, and 5.2\u2003mg\/kg dose groups, respectively. The mean AUC<jats:sub>0\u2010LLOQ<\/jats:sub>from lowest to highest dose groups were 157, 268, and 645\u2003ng\u00b7h\/mL and were dose proportional with a<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>value of 0.9818. Adverse reactions were limited to the highest dose group and included sedation (four of six dogs) and decreased food and water intake (one dog). A dose of 2.6\u2003mg\/kg (50\u2003\u03bcL\/kg) is proposed for further development studies based on the lack of adverse events that were observed compared to the 5.2\u2003mg\/kg group and a more rapid onset of action and longer duration of action compared to the 1.3\u2003mg\/kg group.<\/jats:p>","DOI":"10.1111\/j.1365-2885.2012.01399.x","type":"journal-article","created":{"date-parts":[[2012,6,25]],"date-time":"2012-06-25T18:04:42Z","timestamp":1340647482000},"page":"21-26","source":"Crossref","is-referenced-by-count":18,"title":["Pharmacokinetics and dose selection of a novel, long\u2010acting transdermal fentanyl solution in healthy laboratory Beagles"],"prefix":"10.1111","volume":"35","author":[{"given":"K. J.","family":"FREISE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"SAVIDES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. L.","family":"RIGGS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. G.","family":"OWENS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. C.","family":"NEWBOUND","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. P.","family":"CLARK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,6,25]]},"reference":[{"key":"e_1_2_9_2_1","volume-title":"Veterinary Pharmacology and Therapeutics","author":"Adams H.R.","year":"2001"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198410000-00001"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-198706000-00010"},{"key":"e_1_2_9_5_1","volume-title":"Dermatological Formulations: Percutaneous Absorption","author":"Barry B.W.","year":"1983"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-3659(87)90066-6"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(88)90275-X"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-2995.2006.00310.x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.2012.01411.x"},{"key":"e_1_2_9_10_1","first-page":"21","article-title":"Postoperative pain management using fentanyl patches in dogs","volume":"42","author":"Gilbert D.B.","year":"2003","journal-title":"Contemporary Topics in Laboratory Animal Science"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-198804000-00006"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.5326\/0400468"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-950X.1999.00513.x"},{"key":"e_1_2_9_14_1","volume-title":"Duragesic (Fentanyl Transdermal System) Full Prescribing Information","author":"Janssen Pharmaceutica Products, L.P.","year":"2005"},{"key":"e_1_2_9_15_1","first-page":"202","article-title":"Evaluation of transdermal morphine and fentanyl pluronic lecithin organogel administration in dogs","volume":"5","author":"Krotscheck U.B.D.","year":"2004","journal-title":"Veterinary Therapeutics"},{"key":"e_1_2_9_16_1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2460\/ajvr.1996.57.05.715","article-title":"Disposition of transdermally administered fentanyl in dogs","volume":"57","author":"Kyles A.E.","year":"1996","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0034-5288(98)90151-5"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-5616(08)70004-4"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2004.65.1697"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/js9800275"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1021\/js980026c"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1021\/js980025k"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198312000-00009"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-006-9186-4"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-5616(08)70005-6"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(01)00157-0"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.5326\/15473317-35-2-95"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-2995.2005.00266.x"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-2995.2006.00302.x"}],"container-title":["Journal of Veterinary Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2885.2012.01399.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2885.2012.01399.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T02:35:57Z","timestamp":1714098957000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2885.2012.01399.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,25]]},"references-count":28,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.1111\/j.1365-2885.2012.01399.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2885.2012.01399.x","archive":["Portico"],"relation":{},"ISSN":["0140-7783","1365-2885"],"issn-type":[{"value":"0140-7783","type":"print"},{"value":"1365-2885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,25]]}}}